Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Nebraska Legislature Advances Ultrasound Viewing Bill
The Nebraska Legislature on Wednesday voted to advance a bill (L.B. 675) that would require abortion providers who perform ultrasounds on women seeking the procedure to tell women that a view of the fetus will be available and display the screen in a way that the image can be easily seen, the AP/Lincoln Journal Star reports. The bill also would require the state to compile a list of clinics that offer no-cost ultrasound services. State Sen. Brenda Council (D) criticized that particular provision, saying it would force the state Department of Health and Human Services to spend more taxpayer money.Lawmakers advanced the bill by voice vote after approving an amendment to clarify language surrounding the qualifications of health professionals performing ultrasounds. Advocates for the bill claim it would provide more information to women seeking abortion procedures, while opponents of the bill argue that it would allow the government to interfere in a private procedure. The bill faces a final vote before going to Gov. Dave Heineman (R). If the bill becomes law, Nebraska would join more than a dozen states that have similar laws, the AP/Journal Star reports (Ortiz, AP/Lincoln Journal Star, 5/27).

Call For 'Radical Overhaul' Of Funding Of Long-Term Care In The UK
A new model for the funding of long-term care for older people is needed in the UK, delegates at the Actuarial Profession"s Health and Care Conference in Glasgow heard today.
News of the day
Diabetes UK Reaches Twitter Milestone
Diabetes UK has just reached the 1,000 follower mark on Twitter, the social networking and micro-blogging site that allows its users to send and receive each other"s updates, or "tweets".
Health Insurance

Health Canada Update About Safety Of Lantus (Insulin Glargine)

Health Canada is informing Canadians of an ongoing safety review of the potential association between the diabetes drug Lantus (insulin glargine) and an increased risk of developing cancer. A similar review was recently announced by the U.S. Food and Drug Administration and the European Medicines Agency in light of four recently published studies that looked at the use of Lantus and the development of various types of cancer in patients with diabetes. Three of the four studies suggested a very slightly increased risk of cancer associated with use of Lantus, while the fourth study found no link between the drug and the development of cancer. In all studies, the number of patients who developed cancer was small. The four studies were published in Diabetologia. Lantus is a long-acting synthetic insulin similar to human insulin that is used to control blood sugar in people with type 1 and type 2 diabetes. It has been marketed in Canada since February 2005 by the company Sanofi-Aventis. At this time, Health Canada recommends that patients should not stop taking their insulin therapy without first consulting their physician, as uncontrolled blood sugar can have both immediate and long term serious health consequences. Patients should contact their health care professional if they have any concerns about the medicines they are taking. Health Canada has not concluded that there is a relationship between Lantus and the development of cancer. The Department is currently assessing available safety data, including the studies, to better understand the risk, if any. Health Canada will inform Canadians and health care professionals of new safety information as it emerges, as appropriate. You can report any adverse reactions associated with the use of Lantus to the Canada Vigilance Program by one of the following three ways: - Report online at the MedEffect™ Canada section of the Health Canada Web site - Call toll-free at 1-866-234-2345 - Complete a Canada Vigilance Reporting Form and either: Fax toll-free to 1-866-678-6789 Mail to: Canada Vigilance Program Health Canada AL 0701C Ottawa, ON K1A 0K9 Health Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009